SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced the expansion of its Axiom product line with the launch of the Axiom™ Genome-Wide CHB 1 Array, the first commercial product to maximize genetic coverage of common alleles in Han Chinese populations. This array is the third population-designed array for the Axiom™ Genotyping Solution and one of several additional arrays commercialized this year.
